01452nam a2200325 a 4500007606650MiAaHDL20130605000000.0m d cr bn ---auaua870616m19861987xxuak f000 0 eng d 86601905 //r87sdr-pst.a886557sdr-ucr.b19379298(OCoLC)13645524LIAS1277501PStWaOLNKF27.E5546 1985k1019-A, 1019-B (microfiche)Y 4.En 2/3:99-156Y 4.En 2/3:99-61United States.Congress.House.Committee on Energy and Commerce.Subcommittee on Oversight and Investigations.Prescription drug diversion and counterfeiting :hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first-[second] session.Washington :U.S. G.P.O.,1986-1987.2 v. :ill., forms ;24 cm."Serial no. 99-156"--Pt. 2."Serial no. 99-61"--Pt. 1.Distributed to some depository libraries in microfiche.Part 2: Hearings held July 10, 15, and 16, 1986.Part 1: Hearings held July 10, August 7, September 19, October 31, and December 6, 1985.Mode of access: Internet.Foreign trade regulationUnited States.Product counterfeitingUnited States.Drug controlUnited States.Pharmaceutical industryUnited States.00760665020130605000000.020130709225806.02025-10-16T18:28:25Z2025-10-16T17:50:03ZSDR-PSTUNKNOWNloader.pl-002-002BKsdr-pst.a886557pstSDRPSTpst.000010596913PST4.En 2/3:99-61a886557PSTPST20251016googlepst.0000105969134.En 2/3:99-611987pdbibUS fed docPSTPST20251016googlepst.0000127581114.En 2/3:99-1561987pdbibUS fed docUCUCR20240505googleuc1.312100163311161987pdbibUS fed doc